Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
RNF183 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DAPP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC4A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDAC9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM74 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DGKA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SORBS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ESRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDIA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TEX22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR137C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INPP4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DTWD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCR5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SERPINB9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on